Emerging Respiratory Pathogen Award - American Lung Association
Funds research on the biology, spread, and long-term effects of respiratory infections and emerging pathogens to improve lung health.
Funder: American Lung Association
Due Dates (Anticipated): September 2026 (Letter of Intent) | December 2026 (Full application)
Funding Amounts: $100,000 per year for up to 2 years (total up to $200,000); no indirect costs allowed.
Summary: Supports innovative research on the causes, biology, and long-term effects of respiratory infections and emerging pathogens to improve lung health outcomes.
Key Information: Applicants may submit only one application/LOI per cycle and may receive this award only once.
Description
The Emerging Respiratory Pathogen Award from the American Lung Association funds research to advance understanding of the biology, spread, and health impacts of respiratory infections—including both known and novel pathogens. The award encourages studies on the basic biology of respiratory viruses, host factors affecting infection response, social and regional determinants of virus spread, epidemiology, tracking, long-term sequelae (e.g., post-COVID-19 effects), and lessons learned from recent pandemics. The goal is to foster innovation and discovery that can lead to improved treatments, prevention strategies, and public health outcomes related to lung disease.
